Literature DB >> 26516461

Basic opioid pharmacology: an update.

Hasan Pathan1, John Williams2.   

Abstract

Opioids are a group of analgesic agents commonly used in clinical practice. There are three classical opioid receptors (DOP, KOP and MOP), while the novel NOP receptor is considered to be a non-opioid branch of the opioid receptor family. Opioids can act at these receptors as agonists, antagonists or partial agonists. Opioid agonists bind to G-protein coupled receptors to cause cellular hyperpolarisation. Most clinically relevant opioid analgesics bind to MOP receptors in the central and peripheral nervous system in an agonist manner to elicit analgesia. Opioids may also be classified according to their mode of synthesis into alkaloids, semi-synthetic and synthetic compounds.

Entities:  

Keywords:  Analgesics; opioid classification; opioid/pharmacology; pharmacokinetics

Year:  2012        PMID: 26516461      PMCID: PMC4590096          DOI: 10.1177/2049463712438493

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  13 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

Review 2.  Opioids for neuropathic pain.

Authors:  E Eisenberg; E McNicol; D B Carr
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

3.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  Stimulatory effects of opioids.

Authors:  C Harrison; D Smart; D G Lambert
Journal:  Br J Anaesth       Date:  1998-07       Impact factor: 9.166

Review 5.  International Union of Pharmacology. XII. Classification of opioid receptors.

Authors:  B N Dhawan; F Cesselin; R Raghubir; T Reisine; P B Bradley; P S Portoghese; M Hamon
Journal:  Pharmacol Rev       Date:  1996-12       Impact factor: 25.468

Review 6.  Opioid receptor subtypes: fact or artifact?

Authors:  N Dietis; D J Rowbotham; D G Lambert
Journal:  Br J Anaesth       Date:  2011-05-24       Impact factor: 9.166

7.  Morphine, the Proteus of organic molecules.

Authors:  Paul R Blakemore; James D White
Journal:  Chem Commun (Camb)       Date:  2002-06-07       Impact factor: 6.222

8.  Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain.

Authors:  Carsten K Nielsen; Fraser B Ross; Shahrdad Lotfipour; Kamal S Saini; Stephen R Edwards; Maree T Smith
Journal:  Pain       Date:  2007-04-30       Impact factor: 6.961

Review 9.  Oral or transdermal opioids for osteoarthritis of the knee or hip.

Authors:  Eveline Nüesch; Anne Ws Rutjes; Elaine Husni; Vivian Welch; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 10.  Long-term opioid management for chronic noncancer pain.

Authors:  Meredith Noble; Jonathan R Treadwell; Stephen J Tregear; Vivian H Coates; Philip J Wiffen; Clarisse Akafomo; Karen M Schoelles
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more
  79 in total

Review 1.  Neurotoxicology Syndromes Associated with Drugs of Abuse.

Authors:  Rachel A Caplan; Jonah P Zuflacht; Jed A Barash; Corey R Fehnel
Journal:  Neurol Clin       Date:  2020-11       Impact factor: 3.806

Review 2.  Pain pharmacology: focus on opioids.

Authors:  Diego Fornasari
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 3.  The use of intra-articular analgesics to improve outcomes after temporomandibular joint arthrocentesis: a review.

Authors:  Venkatesan Gopalakrishnan; Shakil Ahmed Nagori; Sanjay Kumar Roy Chowdhury; Vivek Saxena
Journal:  Oral Maxillofac Surg       Date:  2018-09-08

4.  Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.

Authors:  Dioneia Araldi; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2019-06-17       Impact factor: 6.167

Review 5.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

Review 6.  Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.

Authors:  Narjeet Khurmi; Perene Patel; Molly Kraus; Terrence Trentman
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

Review 7.  Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Authors:  Amanda M Brandow; Michael R DeBaun
Journal:  Hematol Oncol Clin North Am       Date:  2018-06       Impact factor: 3.722

8.  Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.

Authors:  Jennifer Miles; Jason Howell; Dave Sheridan; George Braucht; Amy Mericle
Journal:  Am J Drug Alcohol Abuse       Date:  2020-02-24       Impact factor: 3.829

Review 9.  Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Authors:  Hossein Ansari; Leila Kouti
Journal:  Curr Pain Headache Rep       Date:  2016-08

10.  Periaqueductal Gray and Rostromedial Tegmental Inhibitory Afferents to VTA Have Distinct Synaptic Plasticity and Opiate Sensitivity.

Authors:  Robyn St Laurent; Valentina Martinez Damonte; Ayumi C Tsuda; Julie A Kauer
Journal:  Neuron       Date:  2020-03-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.